Fomat Medical Research
Nicholas Focil is the founder and CEO of FOMAT Medical Research– an Integrated Research Organization with over 10 years of experience conducting clinical research in a wide variety of therapeutic areas. As CEO of a medical research company, Nicholas aims to diversify clinical trials, bring innovative healthcare to underrepresented populations, and ensure that high-quality data is contributed to the scientific community to create better treatments. In recognition of the company’s innovative advancements in COVID-19 research, FOMAT was even named 2020s Innovative Business of the Year by Oxnard, California’s Chamber of Commerce. Nicholas is currently chairman and co-founder of Febo, an app chosen by the Northern California MIT Healthcare Association as a top 100 healthcare startup (and is part of the Plug and Play ecosystem). Nicholas also became an Execute Board Member of hyperCORE International, the second-largest research organization in the world. This membership is in addition to previous ones where the was once part of the Innovation Steering Committee of ACRP and Forbes Los Angeles Business Council back in 2018. Moreover, as early as 2008, Nicholas has done numerous publications and speaking engagements within the scientific and business fields and is part of his Alma Maters top 40 under 40.